Par Health’s Receives FDA Warning Letter
21 Apr 2026 //
FDA
Par Health Reveals Q3 2025 Financials And Business Update
10 Nov 2025 //
PR NEWSWIRE
Mallinckrodt Spins Off Par Health, Launches Keenova Therapeutics
10 Nov 2025 //
PR NEWSWIRE
21 Apr 2026 //
FDA
10 Nov 2025 //
PR NEWSWIRE
10 Nov 2025 //
PR NEWSWIRE
Market Place
Sourcing Support